Year: 2020
Type: article
Abstract: Pancreatic adenocarcinomas (PDACs) are scarcely vascularized and thus virtually insensitive to chemotherapy and immunotherapy. In a recent issue of Cell , Lowe and collaborators 1 have demonstrated that senescence induction by MEK plus CDK4/CDK6 inhibitors favors PDAC revascularization coupled to infiltration by therapeutically actionable CD8 + T cells.
Source: Cell Reports Medicine
Authors: Giulia Petroni, Lorenzo Galluzzi
Institutions: Weill Cornell Medicine, Université Paris Cité, Yale University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,200
OpenAlex ID: W3028254537
